
PharmID is a healthcare technology company focused on improving medication management and ensuring the integrity of controlled substance waste. Their flagship product, WasteWitness, is a point-of-care solution that uses Raman spectroscopy and AI to verify drug type, concentration, and volume, thereby solving chain of custody challenges and preventing drug diversion. PharmID's technology aims to enhance patient safety, ensure regulatory compliance, and improve accountability in healthcare settings. They partner with hospitals and healthcare systems to implement smarter, safer medication practices. The company is comprised of a team of scientists, chemists, modelers, pharmacists, and software engineers dedicated to this mission.

PharmID is a healthcare technology company focused on improving medication management and ensuring the integrity of controlled substance waste. Their flagship product, WasteWitness, is a point-of-care solution that uses Raman spectroscopy and AI to verify drug type, concentration, and volume, thereby solving chain of custody challenges and preventing drug diversion. PharmID's technology aims to enhance patient safety, ensure regulatory compliance, and improve accountability in healthcare settings. They partner with hospitals and healthcare systems to implement smarter, safer medication practices. The company is comprised of a team of scientists, chemists, modelers, pharmacists, and software engineers dedicated to this mission.
Headquarters: Kirkland, WA
Flagship product: WasteWitness (Raman spectroscopy + AI for controlled-substance waste verification)
Mission since: 2017 (improving controlled-substance handling and patient safety)
Employee count: 12
Total funding (reported): USD 4,730,000 (last reported 2020-03-03)
Medication management and controlled-substance waste integrity in healthcare settings
2017
Healthcare technology; medication safety
USD 4,730,000.00